Table 12.
Logistic regression of achieving a TCVR reduction (improvement) ≥1 category from baseline to 90 days (variables with significant odds ratios and 95% confidence interval not crossing 1.00)
| BSCORE | EXCELLENT | ||
|---|---|---|---|
| Patient-related variables | |||
| Age | per year | 0.98 | |
| Male gender | if male | 0.52 | |
| Controlled SBP and DBP at baseline | if present | 0.50 | |
| Total cardiovascular risk: moderate added risk | if present | 5.57 | 3.02 |
| Total cardiovascular risk: high added risk | if present | 11.12 | 3.19 |
| Total cardiovascular risk: very high added risk | if present | 104.28 | 48.44 |
| Conditions and risk factors: no pre-existing | if no pre-existing | 2.07 | 3.66 |
| Conditions and risk factors: diabetes | if present | 0.19 | |
| Conditions and risk factors: dyslipidemia | if present | 0.71 | |
| Concomitant antihypertensive treatment: alfa blocker | if present | (0.51) | |
| Concomitant antihypertensive treatment: other than alfa blocker | if present | (2.28) | |
| Physician-rated adherence | per point (0–100 scale) | 1.03 | 1.02 |
| Physician-related variables | |||
| Correct responses to questions related to evidence-based hypertension management | per response (0–4) | (0.78) |
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure; TCVR, total cardiovascular risk.